InsidersTradesSigma
Track the 차바이오텍 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 차바이오텍 has recorded 6 public disclosures. Market capitalisation: €826.5bn. The latest transaction was filed on 3 July 2026 (Other). Among the most active insiders: 차광렬. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
차바이오텍 is a South Korean biotechnology company focused on developing cell and gene therapies. It is listed on the XKRX market.